SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Spheres who wrote (14979)12/27/2004 8:56:49 PM
From: tom pope  Read Replies (1) | Respond to of 52153
 
You should have asked on Thursday of last week. I probably would have come up with STEM, and perhaps, with luck, even have bought it.

I last sold at $3, btw.



To: Spheres who wrote (14979)12/28/2004 2:30:42 PM
From: keokalani'nui  Read Replies (1) | Respond to of 52153
 
Hopefully, the winners will be Stanford, USF, UCSD, Scripps, Berkeley and in about 20 years, the patients. Commercialization is so far away, I'd predict not one of the existing public stem cell companies makes as an investment.

The stem cell investment story of 2005/6 is going to be in cancer anyway.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News